Intuitive Surgical Inc (ISRG)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

$560.71

Buy

$560.98

arrow-down$-2.76 (-0.49%)

Prices updated at 19 May 2025, 19:49 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.
NASDAQ
arrow-down-0.23%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Dr. Craig H. Barratt,PhD
CEO
Dr. Gary S. Guthart,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
15,638
Head office
1020 Kifer Road
Sunnyvale
United States
94086-5304
mobile
+1 408 523-2100
letter
investor.relations@intusurg.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. Gary S. Guthart,PhD
Director and Chief Executive Officer
1.01m
Mr. Jamie E. Samath
Executive Vice President, Chief Financial Officer and Head, Business Technology
0.60m
Mr. David J. Rosa
President and Director
0.75m
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
0.60m
Ms. Amal M. Johnson
Independent Director
0.09m
Dr. Craig H. Barratt,PhD
Chairman of the Board
0.08m
Ms. Jami Dover Nachtsheim
Independent Director
0.09m
Mr. Lewis Chew
Independent Director
0.06m
Mr. Keith R. Leonard, Jr
Independent Director
0.08m
Mr. Joseph C. Beery
Independent Director
0.08m
Mr. Gary H. Loeb
Executive Vice President, Chief Legal Officerand Chief Compliance Officer
-
Dr. Myriam J. Curet, F.A.C.S.,M.D.
Executive Vice President and Chief Medical Officer
-
Ms. Sreelakshmi Kolli
Independent Director
0.08m
Mr. Robert DeSantis
Executive Vice President and Chief Strategy and Corporate Operations Officer
-
Dr. Amy L. Ladd, M.D.
Independent Director
0.08m
Dr. Monica P. Reed, M.D.
Independent Director
0.08m
Mr. Fredrik C. Widman
Principal Accounting Officer, Vice President and Corporate Controller
-
Mr. Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
-
Dr. Brian E. Miller, PhD
Executive Vice President and Chief Digital Officer
0.55m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc32,665,531
BlackRock Inc31,449,561
State Street Corp15,305,425
T. Rowe Price Associates, Inc.14,469,612
Fidelity Management & Research Company LLC12,173,201

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
10 Dec 2024-
10 Dec 2024-
10 Dec 2024-
10 Dec 2024-
10 Dec 2024-
10 Dec 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
29 Nov 2024-
26 Nov 2024-
26 Nov 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.